Literature DB >> 19060285

Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies.

Ulrich Schiefer1, John P Pascual, Beth Edmunds, Elisabeth Feudner, Esther M Hoffmann, Chris A Johnson, Wolf A Lagrèze, Norbert Pfeiffer, Pamela A Sample, Flemming Staubach, Richard G Weleber, Reinhard Vonthein, Elke Krapp, Jens Paetzold.   

Abstract

PURPOSE: A new, fast-threshold strategy, German Adaptive Thresholding Estimation (GATE/GATE-i), is compared to the full-threshold (FT) staircase and the Swedish Interactive Thresholding Algorithm (SITA) Standard strategies. GATE-i is performed in the initial examination and GATE refers to the results in subsequent examinations.
METHODS: Sixty subjects were recruited for participation in the study: 40 with manifest glaucoma, 10 with suspected glaucoma, and 10 with ocular hypertension. The subjects were evaluated by each threshold strategy on two separate sessions within 14 days in a randomized block design.
RESULTS: SITA standard, GATE-i, and GATE thresholds were 1.2, 0.6, and 0.0 dB higher than FT. The SITA standard tended to have lower thresholds than those of FT, GATE-i, and GATE for the more positive thresholds, and also in the five seed locations. For FT, GATE-i, GATE, and SITA Standard, the standard deviations of thresholds between sessions were, respectively, 3.9, 4.5, 4.2, and 3.1 dB, test-retest reliabilities (Spearman's rank correlations) were 0.84, 0.76, 0.79, and 0.71, test-retest agreements as measured by the 95% reference interval of differences were -7.69 to 7.69, -8.76 to 9.00, -8.40 to 8.56, and -7.01 to 7.44 dB, and examination durations were 9.0, 5.7, 4.7, and 5.6 minutes. The test duration for SITA Standard increased with increasing glaucomatous loss.
CONCLUSIONS: The GATE algorithm achieves thresholds that are similar to those of FT and SITA Standard, with comparable accuracy, test-retest reliability, but with a shorter test duration than FT.

Entities:  

Mesh:

Year:  2008        PMID: 19060285      PMCID: PMC2867595          DOI: 10.1167/iovs.08-2229

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

1.  The SITA perimetric threshold algorithms in glaucoma.

Authors:  J M Wild; I E Pacey; E C O'Neill; I A Cunliffe
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

2.  Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies.

Authors:  Paul H Artes; Aiko Iwase; Yuko Ohno; Yoshiaki Kitazawa; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

Review 3.  [Conventional perimetry I: introduction--basics].

Authors:  U Schiefer; J Pätzold; F Dannheim
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

4.  Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease.

Authors:  Richard P Mills; Donald L Budenz; Paul P Lee; Robert J Noecker; John G Walt; Lisa R Siegartel; Stacy J Evans; John J Doyle
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

Review 5.  [Conventional perimetry. Part 3: Static perimetry: grid--strategy--visualisation].

Authors:  U Schiefer; J Pätzold; B Wabbels; F Dannheim
Journal:  Ophthalmologe       Date:  2006-02       Impact factor: 1.059

6.  Age-dependent normative values for differential luminance sensitivity in automated static perimetry using the Octopus 101.

Authors:  Agnes Hermann; Jens Paetzold; Reinhard Vonthein; Elke Krapp; Stephan Rauscher; Ulrich Schiefer
Journal:  Acta Ophthalmol       Date:  2007-12-07       Impact factor: 3.761

7.  SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma.

Authors:  B Bengtsson; A Heijl
Journal:  Acta Ophthalmol Scand       Date:  1998-08

8.  Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma.

Authors:  B Bengtsson; A Heijl
Journal:  Acta Ophthalmol Scand       Date:  1998-06

9.  Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss.

Authors:  Katarzyna Nowomiejska; Reinhard Vonthein; Jens Paetzold; Zbigniew Zagorski; Randy Kardon; Ulrich Schiefer
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

10.  Comparison of Swedish interactive threshold algorithm and full threshold algorithm for glaucomatous visual field loss.

Authors:  Y Aoki; G Takahashi; K Kitahara
Journal:  Eur J Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 2.597

View more
  32 in total

1.  Optical coherence tomography shows progressive local nerve fiber loss after disc hemorrhages in glaucoma patients.

Authors:  Christoph Kernstock; Janko Dietzsch; Kai Januschowski; Ulrich Schiefer; M Dominik Fischer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-25       Impact factor: 3.117

2.  [New aspects in the therapy of multiple sclerosis and optic neuritis].

Authors:  W Lagrèze; R Diem
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

3.  Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy.

Authors:  M Dominik Fischer; Matthis Synofzik; Christoph Kernstock; Janko Dietzsch; Robert Heidlauf; Julia Schicks; Karin Srulijes; Sarah Wiethoff; Oliver Menn; Daniela Berg; Ludger Schöls; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-10       Impact factor: 3.117

4.  Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.

Authors:  Erin A Boese; Nieraj Jain; Yali Jia; Catie L Schlechter; Cary O Harding; Simon S Gao; Rachel C Patel; David Huang; Richard G Weleber; Melanie B Gillingham; Mark E Pennesi
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

5.  Effect of a variability-adjusted algorithm on the efficiency of perimetric testing.

Authors:  Stuart K Gardiner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

6.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.

Authors:  David G Birch; Paul S Bernstein; Alessandro Iannacone; Mark E Pennesi; Byron L Lam; John Heckenlively; Karl Csaky; Mary Elizabeth Hartnett; Kevin L Winthrop; Thiran Jayasundera; Dianna K Hughbanks-Wheaton; Judith Warner; Paul Yang; Gary Edd Fish; Michael P Teske; Neal L Sklaver; Laura Erker; Elvira Chegarnov; Travis Smith; Aimee Wahle; Paul C VanVeldhuisen; Jennifer McCormack; Robert Lindblad; Steven Bramer; Stephen Rose; Patricia Zilliox; Peter J Francis; Richard G Weleber
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

7.  Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1.

Authors:  Mark E Pennesi; Niamh B Stover; Edwin M Stone; Pei-Wen Chiang; Richard G Weleber
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

8.  [Transcorneal electrical stimulation in primary open angle glaucoma].

Authors:  T Röck; L Naycheva; G Willmann; B Wilhelm; T Peters; E Zrenner; K U Bartz-Schmidt; F Gekeler; A Schatz
Journal:  Ophthalmologe       Date:  2017-10       Impact factor: 1.059

Review 9.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

10.  Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements.

Authors:  Jukka Nevalainen; Jens Paetzold; Eleni Papageorgiou; Pamela A Sample; John P Pascual; Elke Krapp; Bettina Selig; Reinhard Vonthein; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.